Pathfinder Medical

Pathfinder Medical is developing a novel electronic guidance system that will enable clinicians to connect blood vessels in a minimally invasive way.

This platform technology can provide a safer, more reliable way for patients to receive haemodialysis or bypass arterial blockages. Worldwide, these unmet clinical needs represent a £4.2 billion yearly available market

Novel electronic catheter guidance platform technology

Enables safe needle crossing and guidewire placement across vessels

Assistive technology for multiple indications

Novel electronic catheter guidance platform technology

Vasular Access for Dialysis

3.4 Million

Dialysis patients
world wide

[1]

640,000

Surgical AVF
creations per year

[2,3]

Peripheral Arterial Disease

200 Million

patients globally

22-30m with most advanced stage (CTO)

194,000

amputations p.a.
in the US and UK

News

[London, UK – Oct 24th 2025] – Pathfinder Medical, a pioneer in minimally invasive vascular access technologies, is pleased to announce the appointment of Dr. Lorenzo Patrone as its Chief Medical Officer (CMO).